Literature DB >> 22401755

Prediction of cognitive decline based on hemispheric cortical surface maps of FDDNP PET.

Hillary D Protas1, Vladimir Kepe, Kiralee M Hayashi, Andrea D Klunder, Meredith N Braskie, Linda Ercoli, Prabha Siddarth, Susan Y Bookheimer, Paul M Thompson, Gary W Small, Jorge R Barrio, Sung-Cheng Huang.   

Abstract

OBJECTIVES: A cross-sectional study to establish whether a subject's cognitive state can be predicted based on regional values obtained from brain cortical maps of FDDNP Distribution Volume Ratio (DVR), which shows the pattern of beta amyloid and neurofibrillary binding, along with those of early summed FDDNP PET images (reflecting the pattern of perfusion) was performed.
METHODS: Dynamic FDDNP PET studies were performed in a group of 23 subjects (8 control (NL), 8 Mild Cognitive Impairment (MCI) and 7 Alzheimer's Disease (AD) subjects). FDDNP DVR images were mapped to the MR derived hemispheric cortical surface map warped into a common space. A set of Regions of Interest (ROI) values of FDDNP DVR and early summed FDDNP PET (0-6 min post tracer injection), were thus calculated for each subject which along with the MMSE score were used to construct a linear mathematical model relating ROI values to MMSE. After the MMSE prediction models were developed, the models' predictive ability was tested in a non-overlapping set of 8 additional individuals, whose cognitive status was unknown to the investigators who constructed the predictive models.
RESULTS: Among all possible subsets of ROIs, we found that the standard deviation of the predicted MMSE was 1.8 by using only DVR values from medial and lateral temporal and prefrontal regions plus the early summed FDDNP value in the posterior cingulate gyrus. The root mean square prediction error for the eight new subjects was 1.6.
CONCLUSION: FDDNP scans reflect progressive neuropathology accumulation and can potentially be used to predict the cognitive state of an individual.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22401755      PMCID: PMC3839850          DOI: 10.1016/j.neuroimage.2012.02.056

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  29 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  Evaluating storage, retention, and retrieval in disordered memory and learning.

Authors:  H Buschke; P A Fuld
Journal:  Neurology       Date:  1974-11       Impact factor: 9.910

3.  Mapping sulcal pattern asymmetry and local cortical surface gray matter distribution in vivo: maturation in perisylvian cortices.

Authors:  Elizabeth R Sowell; Paul M Thompson; David Rex; David Kornsand; Kevin D Tessner; Terry L Jernigan; Arthur W Toga
Journal:  Cereb Cortex       Date:  2002-01       Impact factor: 5.357

4.  Measuring the thickness of the human cerebral cortex from magnetic resonance images.

Authors:  B Fischl; A M Dale
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

Review 5.  Mapping cortical change in Alzheimer's disease, brain development, and schizophrenia.

Authors:  Paul M Thompson; Kiralee M Hayashi; Elizabeth R Sowell; Nitin Gogtay; Jay N Giedd; Judith L Rapoport; Greig I de Zubicaray; Andrew L Janke; Stephen E Rose; James Semple; David M Doddrell; Yalin Wang; Theo G M van Erp; Tyrone D Cannon; Arthur W Toga
Journal:  Neuroimage       Date:  2004       Impact factor: 6.556

Review 6.  Mild cognitive impairment as a diagnostic entity.

Authors:  R C Petersen
Journal:  J Intern Med       Date:  2004-09       Impact factor: 8.989

7.  Dynamics of gray matter loss in Alzheimer's disease.

Authors:  Paul M Thompson; Kiralee M Hayashi; Greig de Zubicaray; Andrew L Janke; Stephen E Rose; James Semple; David Herman; Michael S Hong; Stephanie S Dittmer; David M Doddrell; Arthur W Toga
Journal:  J Neurosci       Date:  2003-02-01       Impact factor: 6.167

Review 8.  Neuropathological stageing of Alzheimer-related changes.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

Review 9.  Neuroimaging and early diagnosis of Alzheimer disease: a look to the future.

Authors:  Jeffrey R Petrella; R Edward Coleman; P Murali Doraiswamy
Journal:  Radiology       Date:  2003-02       Impact factor: 11.105

10.  Plaque and tangle imaging and cognition in normal aging and Alzheimer's disease.

Authors:  Meredith N Braskie; Andrea D Klunder; Kiralee M Hayashi; Hillary Protas; Vladimir Kepe; Karen J Miller; S-C Huang; Jorge R Barrio; Linda M Ercoli; Prabha Siddarth; Nagichettiar Satyamurthy; Jie Liu; Arthur W Toga; Susan Y Bookheimer; Gary W Small; Paul M Thompson
Journal:  Neurobiol Aging       Date:  2008-11-11       Impact factor: 4.673

View more
  4 in total

Review 1.  Understanding cognitive deficits in Alzheimer's disease based on neuroimaging findings.

Authors:  Meredith N Braskie; Paul M Thompson
Journal:  Trends Cogn Sci       Date:  2013-09-09       Impact factor: 20.229

2.  In vivo characterization of chronic traumatic encephalopathy using [F-18]FDDNP PET brain imaging.

Authors:  Jorge R Barrio; Gary W Small; Koon-Pong Wong; Sung-Cheng Huang; Jie Liu; David A Merrill; Christopher C Giza; Robert P Fitzsimmons; Bennet Omalu; Julian Bailes; Vladimir Kepe
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-06       Impact factor: 11.205

Review 3.  Functional brain connectivity using fMRI in aging and Alzheimer's disease.

Authors:  Emily L Dennis; Paul M Thompson
Journal:  Neuropsychol Rev       Date:  2014-02-23       Impact factor: 7.444

4.  Low background and high contrast PET imaging of amyloid-β with [11C]AZD2995 and [11C]AZD2184 in Alzheimer's disease patients.

Authors:  Anton Forsberg; Anders Juréus; Zsolt Cselényi; Maria Eriksdotter; Yvonne Freund-Levi; Fredrik Jeppsson; Britt-Marie Swahn; Johan Sandell; Per Julin; Magnus Schou; Jan Andersson; Peter Johnström; Katarina Varnäs; Christer Halldin; Lars Farde; Samuel Svensson
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-01-17       Impact factor: 9.236

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.